The latest figures released on World Tuberculosis Day by the World Health Organization have once again highlighted the alarming scale of tuberculosis (TB) in Pakistan, underscoring the urgent need for decisive and sustained action. Despite being both preventable and curable, TB remains one of the deadliest infectious diseases in the country, claiming tens of thousands of lives every year and affecting hundreds of thousands more.
According to the data, more than 669,000 people in Pakistan are infected with TB annually, while approximately 51,000 lose their lives to the disease. These figures are not just statistics; they represent a persistent public health failure in addressing a disease that the global community has long known how to control. Pakistan’s position as the fifth-highest TB burden country in the world, and its staggering contribution of 73 percent of cases in the Eastern Mediterranean region, reflects the magnitude of the challenge and the gaps in the national response.
This year’s theme, “Yes, We Can End TB—Powered by People,” conveys a message of hope and collective responsibility. However, the situation on the ground tells a different story. With over 1,800 new cases emerging every day and around 140 deaths daily, the gap between ambition and implementation is stark. The warning from the WHO’s country representative—that one person in Pakistan dies of TB every ten minutes—should serve as a powerful reminder of the urgency of the crisis. More importantly, the fact that these deaths are largely preventable raises serious questions about accountability and the effectiveness of current policies.
The concerns raised by the Pakistan Medical Association further highlight systemic weaknesses within the country’s healthcare system. Chronic underfunding remains one of the most significant barriers to effective TB control. Public health spending has historically been low, limiting the government’s ability to invest in infrastructure, medical supplies, and human resources. As a result, many healthcare facilities lack the capacity to diagnose and treat TB patients efficiently.
Shortages of essential medicines and diagnostic tools have also undermined efforts to control the disease. Interruptions in drug supply not only delay treatment but can also contribute to the development of drug-resistant strains of TB, which are far more difficult and expensive to treat. These challenges are compounded by a weak healthcare delivery system that struggles to reach remote and underserved communities, where TB prevalence is often highest.
Another critical issue is the lack of equitable access to healthcare. TB disproportionately affects low-income populations, who often face barriers such as limited awareness, financial constraints, and social stigma. Many patients delay seeking treatment due to fear of discrimination or lack of knowledge about the disease. This not only worsens health outcomes but also increases the risk of transmission within communities.
Addressing these challenges requires a comprehensive and sustained approach. Early detection must be prioritised through widespread screening and improved diagnostic capabilities. Ensuring an uninterrupted supply of medicines is equally essential, as is the establishment of patient support systems that encourage treatment adherence. Without these measures, efforts to control TB will remain fragmented and ineffective.
Public awareness campaigns also play a crucial role in combating the disease. Beyond simply providing information, these campaigns must actively address the stigma associated with TB, which continues to be a major barrier to treatment. Encouraging open dialogue and community engagement can help create an environment where individuals feel safe to seek care without fear of social exclusion.
While international organisations such as the World Health Organization and Mercy Corps have been instrumental in supporting TB control efforts, the primary responsibility lies with the national government. Health policy must be treated as a central pillar of development rather than a secondary concern. Increased budgetary allocations, stronger governance, and better coordination between federal and provincial authorities are essential to building a resilient healthcare system.
Investing in public health is not merely a moral obligation; it is also an economic necessity. A healthier population contributes to greater productivity, reduced healthcare costs, and overall national stability. Conversely, the continued spread of TB places a significant burden on the economy, affecting workforce participation and increasing public expenditure on healthcare.
The broader implications of the TB crisis extend beyond the health sector. Persistent high infection rates undermine progress in poverty reduction, education, and social development. In this context, tackling TB is not just about saving lives—it is about securing the country’s future.
In conclusion, the message of hope conveyed by this year’s World Tuberculosis Day theme can only become a reality if it is backed by concrete and sustained action. Pakistan has the knowledge, resources, and international support needed to eliminate TB. What remains uncertain is whether there is sufficient political will to translate these advantages into meaningful progress. Without urgent reforms and a renewed commitment to public health, the country risks perpetuating a cycle of preventable illness and death. The time for action is now, and the cost of inaction is simply too high.